Melanotan I (MT-1), also known as afamelanotide, is a synthetic analogue of the naturally occurring hormone alpha-melanocyte-stimulating hormone (alpha-MSH). It selectively activates MC1 receptors (melanocortin-1 receptors) on melanocytes in the skin, stimulating production of eumelanin, the dark brown/black pigment responsible for tanning. Browse the full peptide library for related compounds.
Afamelanotide (the pharmaceutical version of Melanotan I) has received regulatory approval in Europe and the USA for the treatment of erythropoietic protoporphyria (EPP), a condition that causes extreme sun sensitivity. This makes MT-1 the only melanocortin peptide with an approved clinical version.
Compared to Melanotan II, MT-1 is considered more selective and safer because it primarily activates MC1 receptors rather than MC3/MC4/MC5 receptors, meaning it produces gradual tanning without the sexual side effects, appetite changes, or spontaneous erections associated with MT-II.